Literature DB >> 27844341

Does the Type of Multisystem Atrophy, Parkinsonism, or Cerebellar Ataxia Impact on the Nature of Sleep Disorders?

Luigi Ferini-Strambi1, Sara Marelli2, Romina Combi3.   

Abstract

Multiple system atrophy (MSA) is a neurodegenerative disease characterized by a combination of autonomic failure, parkinsonism, and/or cerebellar ataxia. The cause of MSA is unknown, but neuropathologically the disease is characterized by widespread α-synuclein-positive glial cytoplasmic inclusions and striatonigral and/or olivopontocerebellar neurodegeneration. Two motor phenotypes have been clinically identified: parkinsonian (MSA-P) and cerebellar (MSA-C). In order to elucidate if in addition to the motor abnormalities there are other significant differences between these two phenotypes, we performed a review of the studies on sleep disorders in the two MSA subtypes. Substantially, any significant difference in the sleep structure, as well as in the frequency and severity of the sleep disorders, has been found between MSA-P and MSA-C patients. Recent studies clearly showed similarities between the two MSA subtypes in terms of demographic distributions, natural history of the disease, and survivals. These findings suggest that although the dominant clinical presentations differ between MSA-C and MSA-P, a common pathophysiology may underlie both subtypes of MSA.

Entities:  

Keywords:  MSA-C; MSA-P; Multisystem atrophy; REM sleep behavior disorder; Sleep disorders; Stridor

Mesh:

Year:  2016        PMID: 27844341     DOI: 10.1007/s11910-016-0704-z

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  46 in total

1.  Sleep Disorders in Atypical Parkinsonism.

Authors:  Sabra M Abbott; Aleksandar Videnovic
Journal:  Mov Disord Clin Pract       Date:  2014-06-01

2.  REM sleep behaviour disorder differentiates pure autonomic failure from multiple system atrophy with autonomic failure.

Authors:  G Plazzi; P Cortelli; P Montagna; A De Monte; R Corsini; M Contin; F Provini; G Pierangeli; E Lugaresi
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-05       Impact factor: 10.154

3.  Respiratory insufficiency as the primary presenting symptom of multiple-system atrophy.

Authors:  Graham A Glass; Keith A Josephs; J Eric Ahlskog
Journal:  Arch Neurol       Date:  2006-07

4.  Comparison of the clinical features of rapid eye movement sleep behavior disorder in patients with Parkinson's disease and multiple system atrophy.

Authors:  Takashi Nomura; Yuichi Inoue; Birgit Högl; Yusuke Uemura; Kenichi Yasui; Taeko Sasai; Kazuyoshi Namba; Kenji Nakashima
Journal:  Psychiatry Clin Neurosci       Date:  2011-04       Impact factor: 5.188

5.  Low levels of ventricular CSF orexin/hypocretin in advanced PD.

Authors:  X Drouot; S Moutereau; J P Nguyen; J P Lefaucheur; A Créange; P Remy; F Goldenberg; M P d'Ortho
Journal:  Neurology       Date:  2003-08-26       Impact factor: 9.910

Review 6.  Recent developments in multiple system atrophy.

Authors:  Gregor K Wenning; Nadia Stefanova
Journal:  J Neurol       Date:  2009-05-27       Impact factor: 4.849

7.  Second consensus statement on the diagnosis of multiple system atrophy.

Authors:  S Gilman; G K Wenning; P A Low; D J Brooks; C J Mathias; J Q Trojanowski; N W Wood; C Colosimo; A Dürr; C J Fowler; H Kaufmann; T Klockgether; A Lees; W Poewe; N Quinn; T Revesz; D Robertson; P Sandroni; K Seppi; M Vidailhet
Journal:  Neurology       Date:  2008-08-26       Impact factor: 9.910

Review 8.  The neuropathology, pathophysiology and genetics of multiple system atrophy.

Authors:  Z Ahmed; Y T Asi; A Sailer; A J Lees; H Houlden; T Revesz; J L Holton
Journal:  Neuropathol Appl Neurobiol       Date:  2012-02       Impact factor: 8.090

9.  Natural history of multiple system atrophy in the USA: a prospective cohort study.

Authors:  Phillip A Low; Stephen G Reich; Joseph Jankovic; Clifford W Shults; Matthew B Stern; Peter Novak; Caroline M Tanner; Sid Gilman; Frederick J Marshall; Frederick Wooten; Brad Racette; Thomas Chelimsky; Wolfgang Singer; David M Sletten; Paola Sandroni; Jay Mandrekar
Journal:  Lancet Neurol       Date:  2015-05-27       Impact factor: 44.182

10.  Daytime sleepiness in Japanese patients with multiple system atrophy: prevalence and determinants.

Authors:  Takayoshi Shimohata; Hideaki Nakayama; Masahiko Tomita; Tetsutaro Ozawa; Masatoyo Nishizawa
Journal:  BMC Neurol       Date:  2012-11-01       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.